GENOME ANNOUNCEMENT {#h0.0}
===================

*Pseudomonas aeruginosa* is an opportunistic Gram-negative gammaproteobacterium that is frequently implicated in a wide range of acute and chronic infections---especially infections of chronic wounds, such as pressure ulcers, diabetic ulcers, venous ulcers, and arterial ulcers---and thus represents a significant burden on patients and health care systems. Chronic infections due to *P. aeruginosa*, such as pneumonia in cystic fibrosis patients, are associated with the growth of bacteria within antibiotic-resistant biofilms and their adaptation to the respective niche ([@B1]). *P. aeruginosa* genomes range from 5.8 to 7.3 Mb that comprise a core genome consisting of more than 4,000 genes plus a variable accessory gene pool.

Here, we announce the draft genome sequence of *P. aeruginosa* WS136, isolated from pyoderma gangrenosum of a patient following bone marrow transplantation. It was selected among a set of more than 320 chronic wound isolates that were collected between 2006 and 2008 due to its outstanding phenotype. WS136 was phenotypically characterized as described previously ([@B2]) and was susceptible against all available antipseudomonal antibiotics except colistin. Using O antisera (BioRad, Munich, Germany), it was classified as serotype O3, produced almost no pyocyanin, had extraordinarily high elastase (LasB) activity, and hyperproduced and secreted the type III-dependent exotoxin S (ExoS) ([@B3]). This correlated well with its complete cell cytotoxicity against the mouse macrophage cell line J774.

To obtain a draft genome of this outstanding strain, we extracted genomic DNA to construct a paired-end library for shotgun sequencing with the Genome Sequencer FLX (GS FLX) system by means of the Titanium technology (Roche) as described recently ([@B4][@B5][@B7]). Standard protocols were followed per the manufacturer's instructions. Assembly with the GS *de novo* Assembler software (Newbler) covered 209,590,411 bases from 954,897 aligned individual reads, among them 207,090 paired-end reads. The average size of the paired-end DNA fragments was 2,776 ± 694 bases. The assembly resulted in 92 contigs of at least 500 bp that were organized in 6 scaffolds by utilizing the paired-end information. An *in silico* gap closure approach ([@B7], [@B8]) reduced the contigs to 70. The scaffolds covered 6,548,669 bp, with an average coverage of 32×. The genome had a G+C content of 66.4%. Automated genome annotation was carried out by means of the GenDB software ([@B9]) and predicted 5,968 protein-coding sequences (CDSs) and 69 RNA-coding genes. Comparative analysis employing the EDGAR software ([@B10]) revealed the presence of a wild-type *exoS* gene, the absence of an *exoU* gene, and no significant mutations in the *lasB* gene or its 500-bp upstream region ([@B3]). A more detailed analysis of the genome will contribute to our understanding of wound-infecting pseudomonads and facilitate deeper insights into the combinatorial activity of virulence genes in *P. aeruginosa*.

Nucleotide sequence accession numbers. {#s1}
--------------------------------------

The whole-genome sequencing project for *P. aeruginosa* WS136 has been deposited at EMBL/GenBank/DDBJ under the accession number [CBXZ000000000](CBXZ000000000). Here, the first version (CBXZ000000000.1) of the genome data is described.
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